Nutex Health Extends $25M Stock Buyback Program By Over Six Months, Now Extended to March 31, 2026

Benzinga · 1d ago

Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 25 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced that its Board of Directors has approved an extension of the previously authorized stock repurchase program.

The program, originally announced on August 14, 2025, authorized the repurchase of up to $25.0 million of the Company's common stock over a six-month period, commencing upon the filing of the Company's Form 10-Q for the quarter ended June 30, 2025.

The Board has extended the program through March 31, 2026. The repurchase plan will be implemented in accordance with the provisions of Rule 10b-18 under the Securities Exchange Act of 1934, as amended, and under a Rule 10b5-1 trading plan, which is scheduled to go into effect on or about December 4, 2025.

The purpose of the share repurchase program is to increase shareholder value and offset dilution from the issuance of additional shares related to stock compensation obligations for under-construction and ramping hospitals.